2022 annual financial data

Processa Pharmaceuticals, Inc. 2022 Operating margin

Processa Pharmaceuticals, Inc. 2022 operating margin with verified reported val…

Direct answer

Operating margin was Not calculable.

Operating income was -20,257,288 USD and net income was -27,424,229 USD.
Operating cash flow was -9,605,143 USD.

Get free Processa Pharmaceuticals, Inc. email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
0 USD
Operating income
-20,257,288 USD
Net income
-27,424,229 USD
Operating cash flow
-9,605,143 USD